Clinical Trial Update: SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Seretide (fluticasone propionate/salmeterol) 50/500 mcg with tiotropium in severe COPD; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seretide (fluticasone propionate/salmeterol)
• tiotropium bromide (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED